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Figure S26. 13 C NMR spectrum (300 MHz, 298 K, CDCl3) of 4-methyl-1,3-dioxolan-2-one (Table 2 , entry 1). Figure S27 . 1 H NMR spectrum (300 MHz, 298 K, CDCl3) of 4-chloromethyl-1,3-dioxolan-2-one (Table 2 , entry 2).
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S23
Figure S28. 13 C NMR spectrum (300 MHz, 298 K, CDCl3) of 4-chloromethyl-1,3-dioxolan-2-one ( Table 2 , entry 2). S24 Figure S29 . 1 H NMR spectrum (300 MHz, 298 K, CDCl3) of 4-hydroxymethyl-1,3-dioxolan-2-one (Table 2 , entry 3).
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Figure S30. 13 C NMR spectrum (300 MHz, 298 K, CDCl3) of 4-hydroxymethyl-1,3-dioxolan-2-one (Table 2 , entry 3). Figure S31 . 1 H NMR spectrum (300 MHz, 298 K, CDCl3) of 4-allyloxymethyl-1,3-dioxolan-2-one (Table 2 , entry 4).
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Figure S32. 13 C NMR spectrum (300 MHz, 298 K, CDCl3) of 4-allyloxymethyl -1,3-dioxolan-2-one (Table 2 , entry 4). Figure S33 . 1 H NMR spectrum (300 MHz, 298 K, CDCl3) of 4-phenoxymethyl-1,3-dioxolan-2-one (Table 2 , entry 5).
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Figure S34. 13 C NMR spectrum (300 MHz, 298 K, CDCl3) of 4-phenoxymethyl-1,3-dioxolan-2-one ( Table 2 , entry 5). Figure S35 . 1 H NMR spectrum (300 MHz, 298 K, CDCl3) of 4-phenyl-1,3-dioxolan-2-one (Table 2 , entry 6).
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Figure S36. 13 C NMR spectrum (300 MHz, 298 K, CDCl3) of 4-phenyl-1,3-dioxolan-2-one (Table 2 , entry 6). Figure S37 . 1 H NMR spectrum (300 MHz, 298 K, CDCl3) of cis-1,2-cyclohexene carbonate (Table 2 , entry 7).
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Figure S38. 13 C NMR spectrum (300 MHz, 298 K, CDCl3) of cis-1,2-cyclohexene carbonate (Table 2 , entry 7).
